相似文献
1
The effect of nisoldipine on apparent liver blood flow and effective renal plasma flow.
Br J Clin Pharmacol. 1985 Sep;20(3):235-7. doi: 10.1111/j.1365-2125.1985.tb05066.x.
2
Variability in the pharmacokinetics of nisoldipine as caused by differences in liver blood flow response.
J Clin Pharmacol. 1989 Aug;29(8):714-21. doi: 10.1002/j.1552-4604.1989.tb03405.x.
3
Effects of nisoldipine on renal function in normal volunteers and essential hypertensive patients.
J Cardiovasc Pharmacol. 1989 Jan;13(1):90-3.
4
The contribution of nisoldipine-induced changes in liver blood flow to its pharmacokinetics after oral administration.
Br J Clin Pharmacol. 1989 May;27(5):581-6. doi: 10.1111/j.1365-2125.1989.tb03420.x.
5
The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects.
Eur J Clin Pharmacol. 1985;29(1):21-4. doi: 10.1007/BF00547363.
6
Renal clearance and micropuncture studies of nisoldipine effects in spontaneously hypertensive rats.
J Cardiovasc Pharmacol. 1987;9 Suppl 1:S24-31.
7
Comparison of vasodilating effects of nisoldipine and nifedipine in anesthetized open-chest dogs.
Arzneimittelforschung. 1986 Dec;36(12):1736-9.
8
Inhibitory effect of nisoldipine on angiotensin-II-induced renal actions in anesthetized dogs.
J Cardiovasc Pharmacol. 1989 Jul;14(1):96-102. doi: 10.1097/00005344-198907000-00017.
9
Reversal by the calcium antagonist nisoldipine of norepinephrine-induced reduction of GFR: evidence for preferential antagonism of preglomerular vasoconstriction.
J Pharmacol Exp Ther. 1985 Feb;232(2):382-7.
10
Verapamil pharmacokinetics and apparent hepatic and renal blood flow.
Br J Clin Pharmacol. 1985 Aug;20(2):101-6. doi: 10.1111/j.1365-2125.1985.tb05038.x.
引用本文的文献
1
Clinical pharmacokinetics of nisoldipine coat-core.
Clin Pharmacokinet. 1998 Sep;35(3):191-208. doi: 10.2165/00003088-199835030-00003.
2
Increase in plasma propranolol caused by nicardipine is dependent on the delivery rate of propranolol.
Eur J Clin Pharmacol. 1995;49(1-2):121-5. doi: 10.1007/BF00192370.
3
Drug interactions with thrombolytic agents. Current perspectives.
Clin Pharmacokinet. 1995 Apr;28(4):315-26. doi: 10.2165/00003088-199528040-00004.
4
Verapamil pharmacokinetics.
Br J Clin Pharmacol. 1986 May;21(5):554-5. doi: 10.1111/j.1365-2125.1986.tb02846.x.
5
Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers.
Br J Clin Pharmacol. 1987 Jun;23(6):693-701. doi: 10.1111/j.1365-2125.1987.tb03103.x.
6
Clinical pharmacokinetics of nicotine.
Clin Pharmacokinet. 1987 Jan;12(1):30-40. doi: 10.2165/00003088-198712010-00003.
7
Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin.
Br J Clin Pharmacol. 1986 Aug;22(2):155-9. doi: 10.1111/j.1365-2125.1986.tb05243.x.
8
The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.
Br J Clin Pharmacol. 1988 Jun;25(6):709-17. doi: 10.1111/j.1365-2125.1988.tb05257.x.
9
Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
Drugs. 1988 Dec;36(6):682-731. doi: 10.2165/00003495-198836060-00003.
10
The contribution of nisoldipine-induced changes in liver blood flow to its pharmacokinetics after oral administration.
Br J Clin Pharmacol. 1989 May;27(5):581-6. doi: 10.1111/j.1365-2125.1989.tb03420.x.
本文引用的文献
1
[Effects of intravenous nicardipine hydrochloride (YC 93), a calcium antagonist, on renal function (author's transl)].
Nihon Jinzo Gakkai Shi. 1981 Aug;23(8):1143-51.
2
Effect of food on hepatic blood flow: implications in the "food effect" phenomenon.
Clin Pharmacol Ther. 1983 Sep;34(3):316-23. doi: 10.1038/clpt.1983.174.
3
Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects.
Br J Clin Pharmacol. 1984 Jan;17(1):83-5. doi: 10.1111/j.1365-2125.1984.tb05003.x.
4
Clinical effects of intravenous nifedipine on renal function.
J Cardiovasc Pharmacol. 1983 Jan-Feb;5(1):67-71. doi: 10.1097/00005344-198301000-00010.
5
Verapamil pharmacokinetics and apparent hepatic and renal blood flow.
Br J Clin Pharmacol. 1985 Aug;20(2):101-6. doi: 10.1111/j.1365-2125.1985.tb05038.x.
6
Drug kinetics and hepatic blood flow.
Clin Pharmacokinet. 1979 Nov-Dec;4(6):433-48. doi: 10.2165/00003088-197904060-00003.
Zotero 插件